Purely Inspired Turmeric Curcumin
Natural health product licensed in Canada
- Licence holder
- Iovate Health Sciences International Inc.
- NPN or DIN-HM
- 80062754
- Status
- Active licence
- Licence date
- 15 July 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 3,000 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine D: up to 3,000 µg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (100 µg VDE a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 2 milligramme | 6,000 µg |
| Curcuma longa Source : Rhizome | 400 milligramme | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 6.7 milligramme | Not calculated |
| Harpagophytum procumbens Source : Harpagophytum procumbens, racine Extract : Matériel brut sec Extraction ratio : 7:1 Dry plant equivalent : 116.9 milligramme | Not specified | Not calculated |
| Harpagophytum procumbens Source : Harpagophytum procumbens, racine | 16.7 milligramme | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Chlorhydrate de glucosamine | 33.3 milligramme | Not calculated |
| Vitamine A Source : Palmitate de vitamine A | 1 milligramme | Not calculated |
| Vitamine A Source : Palmitate de vitamine A | 0.55 mg RAE | Not calculated |
| Vitamine D Source : Cholécalciférol | 100 Unités internationales | Not calculated |
| Vitamine D Source : Cholécalciférol | 1 milligramme | 3,000 µg |
| Vitamine K1 Source : Vitamine K1 | 2 microgrammes | Not calculated |
| Salix alba Source : Écorce de racine | 16.7 milligramme | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Crospovidone, Huile végétale hydrogénée, Cellulose microcristalline, Hydroxypropylcellulose, Acide stéarique, Stéarate de magnésium, Phosphate de calcium, dibasique, dihydraté, Glycérine, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Used to help relieve joint inflammation. A factor in maintaining healthy cartilage and/or joint health. Helps in the development and maintenance of bones. Used to help relieve minor pain, swelling, and inflammation (anti-inflammatory). A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
- Précautions et mises en garde
If you have a gastrointestinal lesion/ ulcer, are taking an anticoagulant/ blood thinner, anti-inflammatory or antibiotic, or are having surgery, consult a health care practitioner prior to use. If you are taking antiplatelet medication or blood thinners, consult a health care practitioner prior to use. If you have gallstones or a bile duct obstruction, consult a health care practitioner prior to use. If you have stomach ulcers or excess stomach acid, consult a health care practitioner prior to use. If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use. If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80062754
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.